Li Ning Li
Director/Miembro de la Junta en HaploX Investment Holding Ltd. .
Cargos activos de Li Ning Li
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
HaploX Investment Holding Ltd.
 HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong. | Director/Miembro de la Junta | 29/01/2023 | - |
Historial de carrera de Li Ning Li
Antiguos cargos conocidos de Li Ning Li.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| Grains Valley Venture Capital | Director de Operaciones | 01/01/2009 | 02/01/2009 |
Formación de Li Ning Li.
| University of Cardiff | Graduate Degree |
| China Pharmaceutical University | Undergraduate Degree |
Estadísticas
Internacional
| China | 3 |
| Reino Unido | 2 |
| Islas Caimán | 2 |
Operativa
| Director/Board Member | 1 |
| Chief Operating Officer | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Consumer Services | 3 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
| Grains Valley Venture Capital | |
HaploX Investment Holding Ltd.
HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong. | Commercial Services |
- Bolsa de valores
- Insiders
- Li Ning Li
- Experiencia
